Can investors breathe easy with Respiri?

Alan Kohler speaks with Mario Gattino, CEO of Respiri, about their big move into asthma management in India and the suitability of the product for the Australian market.

Become a TCI Community Member Now

Stay up to date and make better informed decisions.
Get access to all this exclusive content and so much more every week!

  • $1 for the first month
  • $25/month membership
  • Cancel anytime, no lock in contract
  • Access to Private Facebook group
  • Smartphone App (coming soon)